Saturday 17 October 2026 Export VRTX’s income statement to Excel — free account

Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $12.0 billion, up 8.90% from fiscal 2024. In the quarter to June 2026, revenue grew 12.5%, EPS grew 7.96% and free cash flow grew 9.25%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for ten consecutive years.

499.39 9.36 −1.84%

Follow VRTX

Alert me

Market cap: $129.0B
P/E: 28.8×
Fwd P/E: 25.5×
Dividend yield: —
F-score: 8/9
Altman Z: 12.06
Beneish M: −2.17
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	22.31%	22.54%	24.20%	23.54%
Piotroski F-Score Full definition →		8	8	8	6
ROA Full definition →		15.60%	16.41%	17.58%	17.12%
ROIC Full definition →		22.62%	21.63%	24.15%	24.09%
Return on Tangible Assets Full definition →		48.87%	44.62%	45.87%	42.89%
Average Days of Receivables Full definition →		60.60	62.43	59.63	61.89
Free Cash Flow per Share Full definition →		13.06	12.49	14.60	14.96
Free Cash Flow Full definition →		3,337.20	3,193.80	3,710.30	3,796.10
Capital Expenditures Full definition →		(380.80)	(437.60)	(530.30)	(496.80)
Other line items
Cash ROIC Full definition →		14.14%	12.64%	13.94%	13.51%
Accounts Receivable Turnover Full definition →		6.34	6.55	6.43	6.25
Accounts Payable Turnover Full definition →		3.94	3.78	3.60	4.04
Inventory Turnover Full definition →		1.19	1.14	1.08	1.08
Average Days of Payables Full definition →		95.36	102.05	106.24	88.93
Days of Inventory on Hand Full definition →		369.11	372.85	383.59	365.48
Tax Rate Full definition →		(0.17)	(0.15)	(0.16)	(0.16)
Research and Development Expense of Revenue Full definition →		33.56%	32.58%	31.85%	31.04%
Selling, General and Administrative Expense of Revenue Full definition →		14.02%	14.61%	15.14%	15.95%
Share Based Compensation of Revenue Full definition →		5.94%	5.72%	5.62%	5.47%
Interest Coverage Full definition →		311.98	208.67	—	—
Operating CF/Net income Full definition →		1.01	0.92	0.98	0.97
Depreciation/Fixed assets Full definition →		0.14	0.14	0.14	0.13
Capex/Depreciation Full definition →		(1.90)	(2.09)	(2.44)	(2.24)
Revenue per Share Full definition →		45.87	46.94	48.08	49.61
Operating CF per Share Full definition →		14.55	14.20	16.69	16.92
Capex per Share Full definition →		(1.49)	(1.71)	(2.09)	(1.96)
Capex to Sales Full definition →		0.03	0.04	0.04	0.04

Show all line items

Columns are period end dates

Stockrow Weekly